Chronic obstructive pulmonary disease (COPD) affects 25 million people in the U.S. and is the fifth leading cause of death from disease – on track to be the third by 2035 if nothing changes. Gaps in treatment, policy inaction, and access barriers give way to high rates of ER visits, hospital admissions, readmissions, and worse. With 150,000 deaths each year and direct-medical costs reaching $31 billion annually, COPD remains an urgent but underprioritized health crisis.  
 
Will the new administration breathe new life into COPD care? How should gaps in treatment be addressed? How can public and private partnerships improve patient outcomes? What does a comprehensive COPD policy framework look like, and when can we expect it? And how can patients with COPD prioritize their own health in the meantime?  
 
Join The Hill as we convene leaders in the Administration, Congress, and COPD advocacy to answer these questions and more.